183 related articles for article (PubMed ID: 35008722)
1. A Novel Role of BIRC3 in Stemness Reprogramming of Glioblastoma.
Wu Q; Berglund AE; MacAulay RJ; Etame AB
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008722
[TBL] [Abstract][Full Text] [Related]
2. BIRC3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitats.
Wang D; Berglund AE; Kenchappa RS; MacAulay RJ; Mulé JJ; Etame AB
Sci Rep; 2017 Aug; 7(1):9350. PubMed ID: 28839258
[TBL] [Abstract][Full Text] [Related]
3. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
[TBL] [Abstract][Full Text] [Related]
4. HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells.
Tilghman J; Wu H; Sang Y; Shi X; Guerrero-Cazares H; Quinones-Hinojosa A; Eberhart CG; Laterra J; Ying M
Cancer Res; 2014 Jun; 74(11):3168-79. PubMed ID: 24710409
[TBL] [Abstract][Full Text] [Related]
5. Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma.
Kang H; Lee S; Kim K; Jeon J; Kang SG; Youn H; Kim HY; Youn B
J Exp Clin Cancer Res; 2021 Sep; 40(1):282. PubMed ID: 34488821
[TBL] [Abstract][Full Text] [Related]
6. TGFβ-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme.
Ghosh D; Ulasov IV; Chen L; Harkins LE; Wallenborg K; Hothi P; Rostad S; Hood L; Cobbs CS
Stem Cells; 2016 Sep; 34(9):2276-89. PubMed ID: 27354342
[TBL] [Abstract][Full Text] [Related]
7. BIRC3 is a novel driver of therapeutic resistance in Glioblastoma.
Wang D; Berglund A; Kenchappa RS; Forsyth PA; Mulé JJ; Etame AB
Sci Rep; 2016 Feb; 6():21710. PubMed ID: 26888114
[TBL] [Abstract][Full Text] [Related]
8. Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression.
Guerrero PA; Tchaicha JH; Chen Z; Morales JE; McCarty N; Wang Q; Sulman EP; Fuller G; Lang FF; Rao G; McCarty JH
Oncogene; 2017 Nov; 36(47):6568-6580. PubMed ID: 28783169
[TBL] [Abstract][Full Text] [Related]
9. The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells.
Brodie S; Lee HK; Jiang W; Cazacu S; Xiang C; Poisson LM; Datta I; Kalkanis S; Ginsberg D; Brodie C
Oncotarget; 2017 May; 8(19):31785-31801. PubMed ID: 28423669
[TBL] [Abstract][Full Text] [Related]
10. Morusin inhibits glioblastoma stem cell growth in vitro and in vivo through stemness attenuation, adipocyte transdifferentiation, and apoptosis induction.
Guo H; Liu C; Yang L; Dong L; Wang L; Wang Q; Li H; Zhang J; Lin P; Wang X
Mol Carcinog; 2016 Jan; 55(1):77-89. PubMed ID: 25557841
[TBL] [Abstract][Full Text] [Related]
11. Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.
Kim KH; Seol HJ; Kim EH; Rheey J; Jin HJ; Lee Y; Joo KM; Lee J; Nam DH
Neuro Oncol; 2013 Feb; 15(2):161-71. PubMed ID: 23258844
[TBL] [Abstract][Full Text] [Related]
12. MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine Starvation.
Hansen LJ; Sun R; Yang R; Singh SX; Chen LH; Pirozzi CJ; Moure CJ; Hemphill C; Carpenter AB; Healy P; Ruger RC; Chen CJ; Greer PK; Zhao F; Spasojevic I; Grenier C; Huang Z; Murphy SK; McLendon RE; Friedman HS; Friedman AH; Herndon JE; Sampson JH; Keir ST; Bigner DD; Yan H; He Y
Cancer Res; 2019 Jul; 79(13):3383-3394. PubMed ID: 31040154
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-induced galectin-8 maintains stemness in glioma stem cells via autophagy regulation.
Liu D; Zhu H; Cheng L; Li R; Ma X; Wang J; Wang J; Zhang S; Li Y; Shu K; Yu X; Li C
Neuro Oncol; 2024 May; 26(5):872-888. PubMed ID: 38158714
[TBL] [Abstract][Full Text] [Related]
14. CSNK1D is associated with stemness and invasiveness in glioblastoma.
Liu Y; He W; Guo Y; Qu S; Yao F; Liu J; Chai J; Yang Y; Xu T; Liu Y; Yang D; Jia Q; Li M
Pathol Res Pract; 2022 Dec; 240():154187. PubMed ID: 36327821
[TBL] [Abstract][Full Text] [Related]
15. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
Sareddy GR; Pratap UP; Venkata PP; Zhou M; Alejo S; Viswanadhapalli S; Tekmal RR; Brenner AJ; Vadlamudi RK
Stem Cells; 2021 May; 39(5):536-550. PubMed ID: 33470499
[TBL] [Abstract][Full Text] [Related]
16. CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway.
Fukasawa K; Kadota T; Horie T; Tokumura K; Terada R; Kitaguchi Y; Park G; Ochiai S; Iwahashi S; Okayama Y; Hiraiwa M; Yamada T; Iezaki T; Kaneda K; Yamamoto M; Kitao T; Shirahase H; Hazawa M; Wong RW; Todo T; Hirao A; Hinoi E
Oncogene; 2021 Apr; 40(15):2803-2815. PubMed ID: 33727660
[TBL] [Abstract][Full Text] [Related]
17. DYRK1A Negatively Regulates CDK5-SOX2 Pathway and Self-Renewal of Glioblastoma Stem Cells.
Chen B; McCuaig-Walton D; Tan S; Montgomery AP; Day BW; Kassiou M; Munoz L; Recasens A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924599
[TBL] [Abstract][Full Text] [Related]
18. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
[No Abstract] [Full Text] [Related]
19. REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis.
Marisetty AL; Lu L; Veo BL; Liu B; Coarfa C; Kamal MM; Kassem DH; Irshad K; Lu Y; Gumin J; Henry V; Paulucci-Holthauzen A; Rao G; Baladandayuthapani V; Lang FF; Fuller GN; Majumder S
Neuro Oncol; 2019 Jun; 21(6):775-785. PubMed ID: 30953587
[TBL] [Abstract][Full Text] [Related]
20. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca
Shin HJ; Lee S; Jung HJ
J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
